- Category
- Micro (2023-24)
- Udyam number
- UDYAM-CH-01-0012231

Zoydec Pharmaceuticals Private Limited
About Zoydec Pharmaceuticals Private Limited
Data last updated:
Zoydec Pharmaceuticals Private Limited is a private limited company based in Chandigarh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 31 December 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Chandigarh, under CIN U24230CH2020PTC043424. Its GSTIN is 04AABCZ6619C1ZJ (Chandigarh).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Rohan and Pardeep Kumar Singh.
Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Scf 283 Motor Market Commercial Complex Manimajra, Chandigarh, India – 160101.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.25 Cr, a growth of 19% compared to the previous year. For the same year it recorded a net profit of ₹83,597 (net margin 0.7%) and EBITDA of ₹6.06 Lakh (EBITDA margin 4.8%). Revenue has grown at a compounded annual rate (CAGR) of 29% over three years.
Zoydec Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-CH-01-0012231).
Company details
Recognitions & Rankings of Zoydec Pharmaceuticals
Contact details
Zoydec Pharmaceuticals Private Limited's registered office is in Chandigarh, Chandigarh.
- Registered AddressScf 283 Motor Market Commercial Complex Manimajra, Chandigarh, India – 160101
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Zoydec Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Zoydec Pharmaceuticals Private Limited, buy the company report.
Financials of Zoydec Pharmaceuticals Private Limited
FY 2025 filings availableZoydec Pharmaceuticals Private Limited reported revenue of ₹1.25 Cr (up 19% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 29% over three years, including 19% growth in the latest year. EBITDA rose 41% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹6.06 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹83,597 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4.8% | ||||
| Net Profit Margin | 0.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Zoydec Pharmaceuticals Private Limited, buy the company report.
Board of directors of Zoydec Pharmaceuticals Private Limited
Zoydec Pharmaceuticals has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rohan | Director | 31 Dec 2020 | 5 Years 10 Months | Current |
| Pardeep Kumar Singh | Director | 31 Dec 2020 | 5 Years 10 Months | Current |
Peer comparison
Zoydec Pharmaceuticals Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Narix Pharmaceuticals Private Limited | ₹1.26 Cr (FY 2025) | 61.0% | Mumbai, Maharashtra, India | |||
| Douglas Pharmaceuticals Private Limited | ₹1.26 Cr (FY 2025) | -18.0% | Hyderabad, Telangana, India | |||
| Demexico Pharmaceuticals Private Limited | ₹1.26 Cr (FY 2024) | 5.0% | Dehradun, Uttarakhand, India | |||
| Meticue Pharmaceuticals Private Limited | ₹1.26 Cr (FY 2025) | 23.0% | New Delhi, Delhi, India | |||
| Zoydec Pharmaceuticals Private Limitedthis company | ₹1.25 Cr (FY 2025) | ₹83,597 | 0.7% | 19.0% | Chandigarh, India | |
| Revanex Pharmaceuticals Private Limited | ₹1.25 Cr (FY 2025) | 187.0% | Siliguri, West Bengal, India | |||
| Bageo Pharmaceuticals Private Limited | ₹1.24 Cr (FY 2022) | 45.0% | Salem, Tamil Nadu, India |
To see the full peer comparison of Zoydec Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Zoydec Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Zoydec Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Zoydec Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 04AABCZ6619C1ZJ | Chandigarh | Active | 30 Mar 2021 |
To see the full GST registrations and return filing status of Zoydec Pharmaceuticals Private Limited, buy the company report.
Recent activity
Zoydec Pharmaceuticals Private Limited has 4 board changes on record since 2020: 2 appointments and 2 cessations. The latest: Mohit Kumar ceased to be Director on 31 Aug 2022.
Frequently asked questions
Zoydec Pharmaceuticals is an active private limited company based in Chandigarh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 31 December 2020 (6+ years old) and is registered under CIN U24230CH2020PTC043424.
Zoydec Pharmaceuticals has 2 current directors:
- Rohan - Director
- Pardeep Kumar Singh - Director
The latest financial statements of Zoydec Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 29 September 2025. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Zoydec Pharmaceuticals is 04AABCZ6619C1ZJ, registered in Chandigarh.
The CIN (Corporate Identification Number) of Zoydec Pharmaceuticals is U24230CH2020PTC043424. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Zoydec Pharmaceuticals was incorporated on 31 December 2020, making it 6+ years old. It is registered with the Registrar of Companies, Chandigarh.
The peers of Zoydec Pharmaceuticals by revenue are Narix Pharmaceuticals Private Limited, Douglas Pharmaceuticals Private Limited, Demexico Pharmaceuticals Private Limited, Meticue Pharmaceuticals Private Limited, Revanex Pharmaceuticals Private Limited and 1 more, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Mohit Kumar ceased to be Director on 31 Aug 2022. Rohit Chauhan ceased to be Director on 31 Aug 2022. Pardeep Kumar Singh was appointed as Director on 31 Dec 2020. Zoydec Pharmaceuticals has 4 board changes on record in total.
Yes, Zoydec Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-CH-01-0012231).
The registered office of Zoydec Pharmaceuticals is at Scf 283 Motor Market Commercial Complex Manimajra, Chandigarh, India – 160101.
Zoydec Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.

